
Celldex Therapeutics CLDX
€ 27.32
-1.82%
Celldex Therapeutics DPO | CLDX
DPO Jährlich Celldex Therapeutics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.06 K | 6.17 K | 4.16 K | 8.34 K | 4.15 K | 2.03 K | 4.09 K | 726 | 901 | 370 | - | - | 351 | 25.2 | 37.4 | - | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 8.34 K | 25.2 | 2.72 K |
DPO anderer Aktien in der Pharmaeinzelhändler
| Name | DPO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Институт стволовых клеток человека
ISKJ
|
115 | - | - | - | ||
|
Brickell Biotech
BBI
|
105 | - | -5.38 % | $ 6.06 M | ||
|
Clearside Biomedical
CLSD
|
4.48 K | - | - | $ 25.3 M | ||
|
AbbVie
ABBV
|
65.5 | $ 293.87 | 0.19 % | $ 520 B | ||
|
Alnylam Pharmaceuticals
ALNY
|
55 | $ 151.6 | -3.2 % | $ 19.9 B | ||
|
Axon Enterprise
AXON
|
34.3 | $ 302.6 | -0.19 % | $ 23.6 B | ||
|
Theratechnologies
THTX
|
279 | - | - | $ 83.9 M | ||
|
Liquidia Corporation
LQDA
|
189 | $ 51.37 | 7.31 % | $ 4.42 B | ||
|
Bristol-Myers Squibb Company
BMY
|
94 | $ 62.8 | 1.06 % | $ 128 B | ||
|
Titan Pharmaceuticals
TTNP
|
1.88 K | - | -3.76 % | $ 3.47 M | ||
|
CollPlant Biotechnologies Ltd.
CLGN
|
323 | $ 4.0 | -6.76 % | $ 48.8 M | ||
|
Ligand Pharmaceuticals Incorporated
LGND
|
77.8 | $ 317.26 | 0.99 % | $ 6.14 B | ||
|
Eli Lilly and Company
LLY
|
142 | $ 1 432.7 | 1.47 % | $ 1.29 T | ||
|
Crinetics Pharmaceuticals
CRNX
|
4.83 K | $ 84.95 | 0.13 % | $ 7.99 B | ||
|
Mesoblast Limited
MESO
|
1.25 K | $ 14.0 | -3.06 % | $ 16.9 B | ||
|
CorMedix
CRMD
|
79.3 | $ 5.37 | -2.1 % | $ 387 K | ||
|
Adaptimmune Therapeutics plc
ADAP
|
43.9 K | - | -15.15 % | $ 60.3 M | ||
|
MannKind Corporation
MNKD
|
108 | $ 4.22 | 0.84 % | $ 1.29 B | ||
|
AVEO Pharmaceuticals
AVEO
|
547 | - | - | $ 521 M | ||
|
Merck & Co.
MRK
|
94.5 | $ 147.75 | -0.68 % | $ 370 B | ||
|
Moderna
MRNA
|
152 | $ 250.79 | -6.77 % | $ 97.6 B | ||
|
Dynavax Technologies Corporation
DVAX
|
52.8 | - | - | $ 2.02 B | ||
|
Novartis AG
NVS
|
102 | $ 163.39 | -0.18 % | $ 317 B | ||
|
Omeros Corporation
OMER
|
2.25 K | $ 17.3 | -1.48 % | $ 1.1 B | ||
|
Oramed Pharmaceuticals
ORMP
|
113 | $ 3.97 | -0.75 % | $ 164 M | ||
|
Puma Biotechnology
PBYI
|
33.2 | $ 8.13 | -3.22 % | $ 407 M |